Net Margin - Imexpharm Corp (VN:IMP) - Alpha Spread
I

Imexpharm Corp
VN:IMP

Watchlist Manager
Imexpharm Corp
VN:IMP
Watchlist
Price: 49 000 VND -1.8%
Market Cap: 3.8T VND
Have any thoughts about
Imexpharm Corp?
Write Note

Net Margin
Imexpharm Corp

11.5%
Current
13%
Average
4.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
11.5%
=
Net Income
239.3B
/
Revenue
2.1T

Net Margin Across Competitors

Country VN
Market Cap 3.8T VND
Net Margin
11%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 843.2B USD
Net Margin
19%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.4T DKK
Net Margin
35%
Country US
Market Cap 385.8B USD
Net Margin
44%
Country US
Market Cap 278.3B USD
Net Margin
22%
Country CH
Market Cap 206.1B CHF
Net Margin
20%
Country UK
Market Cap 240.2B USD
Net Margin
13%
Country CH
Market Cap 191.2B CHF
Net Margin
33%
Country US
Market Cap 162B USD
Net Margin
-5%

Profitability Report

View the profitability report to see the full profitability analysis for Imexpharm Corp.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
11.5%
=
Net Income
239.3B
/
Revenue
2.1T
What is the Net Margin of Imexpharm Corp?

Based on Imexpharm Corp's most recent financial statements, the company has Net Margin of 11.5%.